导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 17.03% | 240/1050 |
| 近一周 | -0.98% | 456/1104 |
| 近一月 | -4.27% | 695/1103 |
| 近一季 | -0.60% | 314/1092 |
| 近半年 | 6.21% | 314/1070 |
| 近一年 | 20.46% | 252/1018 |
| 近两年 | 98.26% | 213/926 |
| 近三年 | 50.09% | 263/834 |
| 成立以来 | 53.12% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
2.84% 264/1070 |
23.61% 360/1101 |
- - |
- - |
| 2025 | 45.43% 241/1065 |
1.86% 653/1014 |
8.50% 146/1038 |
31.62% 337/1050 |
-0.01% 454/1065 |
| 2024 | -11.33% 791/1011 |
-10.01% 770/960 |
-4.26% 587/983 |
9.66% 647/991 |
-6.14% 741/1011 |
| 2023 | -11.99% 396/952 |
0.82% 587/880 |
-4.05% 451/895 |
-8.85% 546/915 |
-0.19% 128/952 |
| 2022 | -21.96% 407/867 |
-13.49% 198/773 |
8.61% 322/806 |
-15.99% 616/845 |
-1.13% 495/867 |
| 2021 | -0.06% 353/740 |
-14.63% 542/580 |
18.85% 173/659 |
1.25% 200/704 |
-2.72% 534/740 |
| 2020 | 54.12% 220/554 |
-2.84% 231/419 |
23.71% 216/466 |
11.99% 202/517 |
14.49% 214/554 |
| 2019 | 27.18% 302/410 |
30.05% 375/1146 |
-10.26% 1084/1228 |
1.82% 282/390 |
7.03% 274/410 |
| 2018 | -30.26% 220/349 |
- - |
-12.48% 617/990 |
-7.08% 583/1000 |
-12.73% 696/1080 |
| 2017 | -11.61% 195/285 |
- - |
- - |
- - |
- - |
| 2016 | 5.77% 16/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8665 | 61.36% |
| 招商前沿医疗保健股票C | 0.8313 | 61.04% |
| 招商医药健康产业股票 | 2.7000 | 53.78% |
| 前海开源公共卫生股票A | 0.4844 | 46.12% |
| 广发医药精选股票A | 1.3562 | 44.63% |
| 嘉实医疗保健股票 | 2.6570 | 42.34% |
| 前海开源公共卫生股票C | 0.4741 | 42.24% |
| 广发医药精选股票C | 1.3346 | 40.86% |
| 交银医药创新股票A | 2.9498 | 37.46% |
| 交银医药创新股票C | 3.1324 | 37.26% |
| 南方量化成长 VS. 东吴新产业精选股票A(580008) |